Residual expression of SMYD2 and SMYD3 is associated with the acquisition of complex karyotype in chronic lymphocytic leukemia (2016)
- Authors:
- Autor USP: REGO, EDUARDO MAGALHÃES - FMRP
- Unidade: FMRP
- DOI: 10.1007/s13277-016-4846-z
- Subjects: BIOMARCADORES; LEUCEMIA; ABERRAÇÕES DOS CROMOSSOMOS SEXUAIS; REGULAÇÃO GÊNICA; ESTADIAMENTO DE NEOPLASIAS
- Keywords: Chronic lymphocytic leukemia; Cytogenetic; Complex karyotype; SMYD
- Language: Inglês
- Imprenta:
- Publisher place: Thousand Oaks
- Date published: 2016
- Source:
- Título: Tumor Biology
- ISSN: 1010-4283
- Volume/Número/Paginação/Ano: v. 37, n. 7, p. 9473-9481, 2016
- Este periódico é de acesso aberto
- Este artigo NÃO é de acesso aberto
-
ABNT
OLIVEIRA-SANTOS, Wilson et al. Residual expression of SMYD2 and SMYD3 is associated with the acquisition of complex karyotype in chronic lymphocytic leukemia. Tumor Biology, v. 37, n. 7, p. 9473-9481, 2016Tradução . . Disponível em: https://doi.org/10.1007/s13277-016-4846-z. Acesso em: 26 jan. 2026. -
APA
Oliveira-Santos, W., Rabello, D. do A., Lucena-Araujo, A. R., Oliveira, F. M. de, Rego, E. M., Silva, F. P., & Saldanha-Araujo, F. (2016). Residual expression of SMYD2 and SMYD3 is associated with the acquisition of complex karyotype in chronic lymphocytic leukemia. Tumor Biology, 37( 7), 9473-9481. doi:10.1007/s13277-016-4846-z -
NLM
Oliveira-Santos W, Rabello D do A, Lucena-Araujo AR, Oliveira FM de, Rego EM, Silva FP, Saldanha-Araujo F. Residual expression of SMYD2 and SMYD3 is associated with the acquisition of complex karyotype in chronic lymphocytic leukemia [Internet]. Tumor Biology. 2016 ; 37( 7): 9473-9481.[citado 2026 jan. 26 ] Available from: https://doi.org/10.1007/s13277-016-4846-z -
Vancouver
Oliveira-Santos W, Rabello D do A, Lucena-Araujo AR, Oliveira FM de, Rego EM, Silva FP, Saldanha-Araujo F. Residual expression of SMYD2 and SMYD3 is associated with the acquisition of complex karyotype in chronic lymphocytic leukemia [Internet]. Tumor Biology. 2016 ; 37( 7): 9473-9481.[citado 2026 jan. 26 ] Available from: https://doi.org/10.1007/s13277-016-4846-z - Evaluation of the European LeukemiaNet recommendations for predicting outcomes of patients with acute myeloid leukemia treated in low- and middle-income countries (LMIC): A Brazilian experience
- Thalidomide plus dexamethasone as a maintenance therapy after autologous hematopoietic stem cell transplantation improves progression-free survival in multiple myeloma
- Combining gene mutation with gene expression data improves outcomes prediction in acute promyelocytic leukemia
- Identification of myeloid committed progenitor as the cancer-initiating cell in acute promyelocytic leukemia
- Granulocyte colony-stimulating factor and leukemogenesis
- Improving acute promyelocytic leukemia (APL) outcome in developing countries through networking, results of the International Consortium on APL
- Association between the TP53 Arg72Pro polymorphism and clinical outcomes in acute myeloid leukemia
- Hematopoese: cinética de hemácias, neutrófilos e plaquetas
- Epidemiology and treatment of acute promyelocytic leukemia in Latin America
- Clinical impact of BAALC expression in high-risk acute promyelocytic leukemia
Informações sobre o DOI: 10.1007/s13277-016-4846-z (Fonte: oaDOI API)
How to cite
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
